Rag-1 mutations associated with B-cell-negative scid dissociate the nicking and transesterification steps of V(D)J recombination.
Some patients with B-cell-negative severe combined immune deficiency (SCID) carry mutations in RAG-1 or RAG-2 that impair V(D)J recombination. Two recessive RAG-1 mutations responsible for B-cell-negative SCID, R621H and E719K, impair V(D)J recombination without affecting formation of single-site recombination signal sequence complexes, specific DNA contacts, or perturbation of DNA structure at the heptamer-coding junction. The E719K mutation impairs DNA cleavage by the RAG complex, with a greater effect on nicking than on transesterification; a conservative glutamine substitution exhibits a similar effect. When cysteine is substituted for E719, RAG-1 activity is enhanced in Mn(2+) but remains impaired in Mg(2+), suggesting an interaction between this residue and an essential metal ion. The R621H mutation partially impairs nicking, with little effect on transesterification. The residual nicking activity of the R621H mutant is reduced at least 10-fold upon a change from pH 7.0 to pH 8.4. Site-specific nicking is severely impaired by an alanine substitution at R621 but is spared by substitution with lysine. These observations are consistent with involvement of a positively charged residue at position 621 in the nicking step of the RAG-mediated cleavage reaction. Our data provide a mechanistic explanation for one form of hereditary SCID. Moreover, while RAG-1 is directly involved in catalysis of both nicking and transesterification, our observations indicate that these two steps have distinct catalytic requirements.
Li
W
W
Department of Molecular Biology and Genetics and Howard Hughes Medical Institute, The Johns Hopkins University School of Medicine, Baltimore, Maryland 21205, USA.
Chang
F C
FC
Desiderio
S
S
D001402:B-Lymphocytes / Q000276:immunology; D001483:Base Sequence; D002413:Cations, Divalent; D002460:Cell Line; D004247:DNA / Q000378:metabolism; D017931:DNA Primers / Q000235:genetics; D004951:Esterification; D015322:Gene Rearrangement, B-Lymphocyte; D018398:Homeodomain Proteins / Q000235:genetics*; D006801:Humans; D009154:Mutation; D011995:Recombination, Genetic; D016511:Severe Combined Immunodeficiency / Q000235:genetics* / Q000276:immunology*
D002413:Cations, Divalent; D017931:DNA Primers; D018398:Homeodomain Proteins; C064658:RAG-1 protein; D004247:DNA